Ikena Oncology (IKNA) executive Ecsedy received 105,000 Stock Option (Right to Buy)

Insider transactions reported

Jeffrey Ecsedy (executive at Ikena Oncology Inc., IKNA) reported that they received 105,000 Stock Option (Right to Buy) on Jan 3, 2023.

Reporting person

Ecsedy Jeffrey

Options and other derivatives

Holdings before and after

• Stock Option (Right to Buy): 0 to 105,000 direct

Footnotes from the filing

1. 1. 25% of the shares subject to this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ